drugset / Trial / NCT02625181

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

NCT02625181 ↗

Completed 27034 enrolled Vanderbilt University
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine how automated recommendations are best presented to optimize the adherence to guidelines on prophylaxis for nausea and vomiting after surgery.

Timeline

Start
2016-07
Primary completion
2017-11-02
Completion
2017-11-30

Drugs

EvaluationDrugModalityDoseRoute
Background Alfentanil Other / unclassified — —
Background Aprepitant Other / unclassified — —
Background Desflurane Other / unclassified — —
Background Dexamethasone Small molecule — —
Background Droperidol Small molecule — —
Background Fentanyl Other / unclassified — —
Background Granisetron Other / unclassified — —
Background Haloperidol Other / unclassified — —
Background Hydrocodone Unknown — —
Background Hydromorphone Other / unclassified — —
Background Isoflurane Other / unclassified — —
Background Ketamine Small molecule — —
Background Meclizine Small molecule — —
Background Meperidine Unknown — —
Background Methadone Other / unclassified — —
Background Metoclopramide Small molecule — —
Background Morphine Other / unclassified — —
Background Ondansetron Other / unclassified — —
Background Oxycodone Other / unclassified — —
Background Oxymorphone Small molecule — —
Background Palonosetron Other / unclassified — —
Background Promethazine Small molecule — —
Background Propofol Small molecule — —
Background Ramosetron Small molecule — —
Background Remifentanil Small molecule — —
Background Scopolamine Unknown — —
Background Sevoflurane Other / unclassified — —
Background Sufentanil Other / unclassified — —
Background Tropisetron Small molecule — —
Background dolasetron Small molecule — —

Indications

No indication recorded.